Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Top Cited Papers
- 5 June 2013
- journal article
- practice guideline
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 17 (3), 247-288
- https://doi.org/10.1111/1744-9987.12058
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJAMA, 2011
- Phosphate binders for preventing and treating bone disease in chronic kidney disease patientsEmergencias, 2011
- Consequences and therapy of the metabolic acidosis of chronic kidney diseasePediatric Nephrology, 2010
- Tertiary hyperparathyroidism: Is less than a subtotal resection ever appropriate? A study of long-term outcomesSurgery, 2009
- The impact of diabetes mellitus on vitamin D metabolism in predialysis patientsBone, 2009
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General PopulationArchives of Internal Medicine, 2008
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006